Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$281M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$214M |
| 3 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$212M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$200M |
| 5 |
Amazon
AMZN
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$287M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$222M |
| 3 |
United Parcel Service
UPS
|
+$185M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$159M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.46% |
| 2 | Healthcare | 12.19% |
| 3 | Financials | 11.59% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Vanguard High Dividend Yield ETF
VYM
$81.4B
| $663K | ﹤0.01% |
8,191
+644
| +9% | +$52.7K |
|
2802
Sutro Biopharma
STRO
$416M
| $662K | ﹤0.01% |
6,586
+1,763
| +37% | +$167K |
|
2803
Willdan Group
WLDN
$1.11B
| $657K | ﹤0.01% |
25,736
-761
| -3% | -$20.5K |
|
|
FLNA
2804
Filana Therapeutics
FLNA
$49.8M
| $656K | ﹤0.01% |
56,937
+7,000
| +14% | +$31.6K |
|
|
MGP
2805
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $654K | ﹤0.01% |
+23,359
| New | +$650K |
|
2806
Enliven Therapeutics
ELVN
$4.15B
| $650K | ﹤0.01% |
7,977
-199
| -2% | -$17.9K |
|
2807
Fortress Biotech
FBIO
$91.7M
| $648K | ﹤0.01% |
10,679
+334
| +3% | +$17K |
|
2808
Radiant Logistics
RLGT
$393M
| $648K | ﹤0.01% |
125,961
-112,392
| -47% | -$542K |
|
2809
Hingham Institution for Saving
HIFS
$647M
| $643K | ﹤0.01% |
3,490
-104
| -3% | -$19K |
|
2810
Titan International
TWI
$466M
| $643K | ﹤0.01% |
222,251
+23,099
| +12% | +$50.9K |
|
2811
Genasys
GNSS
$78.3M
| $639K | ﹤0.01% |
103,803
+16,422
| +19% | +$78.2K |
|
2812
Occidental Petroleum Corp Warrants
OXY.WS
$31.5B
| $638K | ﹤0.01% |
+212,492
| New | +$679K |
|
2813
Xeris Biopharma Holdings
XERS
$1.4B
| $638K | ﹤0.01% |
107,496
+14,950
| +16% | +$59.8K |
|
2814
Organogenesis Holdings
ORGO
$301M
| $637K | ﹤0.01% |
165,676
+16,196
| +11% | +$64K |
|
2815
Ooma
OOMA
$590M
| $631K | ﹤0.01% |
48,335
-2,667
| -5% | -$40.7K |
|
|
ARA
2816
DELISTED
American Renal Associates Holdings, Inc
ARA
| $631K | ﹤0.01% |
91,443
+613
| +0.7% | +$4.02K |
|
2817
Capital City Bank Group
CCBG
$898M
| $629K | ﹤0.01% |
33,467
-1,033
| -3% | -$20.3K |
|
2818
Globant
GLOB
$1.6B
| $628K | ﹤0.01% |
3,501
+106
| +3% | +$18.3K |
|
2819
Heritage Insurance Holdings
HRTG
$915M
| $626K | ﹤0.01% |
61,838
-1,919
| -3% | -$23.7K |
|
|
HUD
2820
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $626K | ﹤0.01% |
82,306
-6,425
| -7% | -$39K |
|
2821
Alpha and Omega Semiconductor
AOSL
$942M
| $623K | ﹤0.01% |
48,568
-3,309
| -6% | -$39.9K |
|
2822
Viemed Healthcare
VMD
$448M
| $623K | ﹤0.01% |
72,024
-2,066
| -3% | -$20.8K |
|
2823
Altisource Portfolio Solutions
ASPS
$63.7M
| $622K | ﹤0.01% |
6,135
-339
| -5% | -$32.9K |
|
2824
Citi Trends
CTRN
$582M
| $613K | ﹤0.01% |
24,538
-2,872
| -10% | -$57.3K |
|
2825
West Bancorporation
WTBA
$481M
| $605K | ﹤0.01% |
38,184
-1,353
| -3% | -$22.9K |
|
Similar funds
Charles Schwab's Q3 2020 Portfolio in Review
As of Q3 2020, Charles Schwab held 3,405 positions worth $217B, up 6.5% from $204B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 4.3%. Charles Schwab opened 86 new positions and exited 61, leaving the 3,405-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q3 2020 buy was VanEck JP Morgan EM Local Currency Bond ETF: 6,785,480 shares worth $209M.
- Charles Schwab added most to iShares MBS ETF in Q3 2020, an estimated $281M increase.
- Charles Schwab's biggest Q3 2020 reduction was Dominion Energy, cutting an estimated $287M.
- Charles Schwab fully exited iShares Agency Bond ETF in Q3 2020, selling an estimated $52.9M.
- Charles Schwab's ten largest holdings make up 18% of its $217B portfolio in Q3 2020.
- Charles Schwab opened 86 new positions and closed 61 in Q3 2020.
- Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $217B.
Based on Charles Schwab's 13F filing for Q3 2020, filed 13 Nov 2020.